Login / Signup

Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP®-MS analysis.

Kazuhiko UchiyamaYuji NaitoNobuaki YagiKatsura MizushimaYasuki HigashimuraYasuko HiraiOsamu DohiTetsuya OkayamaNaohisa YoshidaKazuhiro KatadaKazuhiro KamadaOsamu HandaTakeshi IshikawaTomohisa TakagiHideyuki KonishiDaisuke NonakaKyoichi AsadaLyang-Ja LeeKenji TanakaYoshiaki KuriuMasayoshi NakanishiEigo OtsujiYoshito Itoh
Published in: Journal of gastroenterology (2018)
In this case-control validation study, we confirmed high diagnostic performance for CRC using five peptides that were identified in our previous study as serum biomarker candidates for the detection of CRC.
Keyphrases
  • case control
  • mass spectrometry
  • multiple sclerosis
  • ms ms